Barbara Ryan | Investor Relations Officer |
Robert Ward | Chairman and Chief Executive Officer |
Gregory Williams | Chief Operating Officer |
David Snow | Chief Business Officer |
Gregory Weaver | Chief Financial Officer |
Edward Tenthoff | Piper Jaffray |
Shawn Egan | Citigroup Inc |
Joon Lee | SunTrust Robinson Humphrey, Inc. |
Good morning, everyone, and welcome to Eloxx Pharmaceuticals’ Second Quarter 2019 Earnings Webcast and Conference Call. Today’s call is being recorded.
At this time, I’d like to turn the call over to Barbara Ryan, Eloxx Investor Relations Officer. Please begin.
Thank you, operator, and welcome and thank you for joining us this morning for a review of Eloxx Pharmaceuticals’ second quarter 2019 financial results and business update.